Anna L Blobaum Selected Research

VU0467485

2/2017

Discovery of VU0467485/AZ13713945: An M4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna L Blobaum Research Topics

Disease

10	Schizophrenia (Dementia Praecox) 11/2020 - 11/2012
8	Parkinson Disease (Parkinson's Disease) 01/2021 - 02/2012
6	Catalepsy 01/2021 - 11/2011
4	Alzheimer Disease (Alzheimer's Disease) 12/2020 - 11/2012
3	Neoplasms (Cancer) 01/2020 - 03/2002
2	Seizures (Absence Seizure) 01/2019 - 09/2018
2	Chagas Disease (American Trypanosomiasis) 12/2018 - 12/2018
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020
1	Diffuse Intrinsic Pontine Glioma 01/2020
1	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Hyperinsulinism (Hyperinsulinemia) 01/2019
1	Infections 12/2018
1	Visceral Leishmaniasis (Kala Azar) 12/2018
1	Mycoses (Diseases, Fungus) 12/2018
1	Deafness (Deaf Mutism) 01/2018
1	Epilepsy (Aura) 01/2018
1	Ataxia (Dyssynergia) 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	SeSAME syndrome 01/2018
1	Neurodevelopmental Disorders 01/2017
1	Pain (Aches) 01/2017
1	Syndrome (Syndromes) 01/2017
1	Rett Syndrome (Rett's Disorder) 01/2017
1	Central Nervous System Diseases (CNS Diseases) 11/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 11/2015
1	Edema (Dropsy) 05/2013
1	Squamous Cell Carcinoma of Head and Neck 05/2013
1	Fragile X Syndrome (Martin Bell Syndrome) 09/2012
1	Autistic Disorder (Autism) 09/2012
1	Neuroinflammatory Diseases 03/2012
1	Carcinogenesis 03/2012
1	Inflammation (Inflammations) 05/2010

Drug/Important Bio-Agent (IBA)

6	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2022 - 11/2012
6	Haloperidol (Haldol)FDA LinkGeneric 01/2021 - 11/2011
4	Pharmaceutical PreparationsIBA 12/2018 - 01/2017
3	Cholinergic Agents (Cholinergics)IBA 12/2020 - 09/2018
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 11/2015 - 02/2012
2	SterolsIBA 12/2018 - 12/2018
2	benzocycloheptapyridineIBA 01/2018 - 01/2013
2	metabotropic glutamate receptor 4IBA 01/2016 - 01/2016
1	VU6019650IBA 01/2022
1	dipinacoline glutamateIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	VU0652957IBA 03/2019
1	Diazoxide (Hyperstat)FDA Link 01/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	KATP ChannelsIBA 01/2019
1	EnzymesIBA 12/2018
1	benzamideIBA 12/2018
1	Biological ProductsIBA 12/2018
1	Hydroxyl RadicalIBA 09/2018
1	AminesIBA 01/2018
1	DiureticsIBA 01/2018
1	SaltsIBA 01/2018
1	VU0467485IBA 02/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017
1	bovine adrenal medulla 8-22IBA 01/2017
1	Methyl-CpG-Binding Protein 2IBA 01/2017
1	Glutamate Receptors (Glutamate Receptor)IBA 12/2016
1	N-Methylaspartate (NMDA)IBA 12/2016
1	VU0486321IBA 02/2016
1	Blood Proteins (Serum Proteins)IBA 11/2015
1	Metabotropic Glutamate 5 ReceptorIBA 12/2013
1	Cytochrome P-450 CYP3AIBA 12/2013
1	CarrageenanIBA 05/2013
1	Indomethacin (Indometacin)FDA LinkGeneric 05/2013
1	ML253IBA 01/2013
1	Adenosine (Adenocard)FDA LinkGeneric 02/2012
1	Levodopa (L Dopa)FDA LinkGeneric 02/2012
1	N-(3-chlorophenyl)picolinamideIBA 02/2012
1	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 02/2012
1	Oxidopamine (6 Hydroxydopamine)IBA 02/2012
1	Indicators and Reagents (Reagents)IBA 05/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2010
1	Contrast MediaIBA 05/2010
1	ProdrugsIBA 03/2002
1	Ganciclovir (Cytovene)FDA LinkGeneric 03/2002
1	Thymidine KinaseIBA 03/2002
1	2- amino- 1,9- dihydro- 9- (3- hydroxy- 4- (hydroxymethyl)cyclopentyl)- 6H- purine- 6- oneIBA 03/2002

Therapy/Procedure

1	Analgesia 03/2012